Phosphatidylinositol 3-Kinase-Akt Signaling in Pulmonary Carcinoid Cells

Journal of the American College of Surgeons

Volumn 209, Issue 1, 2009, Pages 82-88

  Pitt, Susan C ^a   Chen, Herbert ^a   Kunnimalaiyaan, Muthusamy ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHROMOGRANIN A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR MASH1;

ARTICLE; CARCINOID; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY CARCINOID; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BLOTTING, WESTERN; CARCINOID TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; MORPHOLINES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 67349142331     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.03.006     Document Type: Article

References (20)

1. Modlin I.M., Lye K.D., and Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 (2003) 934-959
2. Pinchot S.N., Holen K., Sippel R.S., and Chen H. Carcinoid tumors. Oncologist 13 (2008) 1255-1269
3. Gustafsson B.I., Kidd M., Chan A., et al. Bronchopulmonary neuroendocrine tumors. Cancer 133 (2008) 5-21
4. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
5. Brognard J., Clark A.S., Ni Y., and Dennis P.A. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular and resistance to chemotherapy and radiation. Cancer Res 61 (2001) 3986-3997
6. Krystal G.W., Sulanke G., and Litz J. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol Cancer Ther 1 (2002) 913-922
7. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signaling pathway in human malignancy. Cellular Signaling 14 (2002) 381-395
8. Toulany M., Kehlbach R., Florczak U., et al. Targeting Akt1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther 7 (2008) 1172-1181
9. Lee M.W., Kim D.S., Min N.Y., and Kim H.T. Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin. Int J Cancer 122 (2008) 2380-2384
10. Kunnimalaiyaan M., Ndiaye M., and Chen H. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Surgery 140 (2006) 1009-1015
11. Greenblatt D.Y., Vaccaro A.M., Jaskula-Sztul R., et al. Valproic acid activates Notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 12 (2007) 942-951
12. Sippel R.S., Carpenter J.E., Kunnimalaiyaan M., et al. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 285 (2003) G245-G254
13. Van Gompel J.J., Kunnimalaiyaan M., Holen K., and Chen H. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther 4 (2005) 910-917
14. Wu C., and Huang J. Phosphatidylinositol 3-kinase-AKT-mammalian target of rapapmycin pathway is essential for neuroendocrine differentiation of prostate cancer. J Biol Chem 282 (2007) 3571-3583
15. Liu H., Radisky D.C., Nelson C.M., et al. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci 103 (2006) 4134-4139
16. Xu C., Jere D., Jin H., et al. Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Resp Crit Care Med 178 (2008) 60-73
17. 2-M delay. Clin Cancer Res 3 (1997) 1149-1156
18. E17K in human solid tumors. Oncogene 27 (2008) 5648-5650
19. Mandal M., Younes M., Swan E.A., et al. The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. Oral Oncol 42 (2006) 430-439
20. Tang H.J., Jin X., Wang S., et al. A small molecule compound inhibits AKT pathway in ovarian cancer cell lines. Gynecol Oncol 100 (2006) 308-317